Access to more than 5000 HCV related scientific abstracts and COMPLETE PAPERS  in an INTERNATIONAL INDEPENDENT NEWSLETTER for HCV-Experts. Free Yahoo-Group-Registration required. Absolute Privacy Respect.

SAMPLE from 2011:

FULL TEXT (Nov 2011, 41 pages): The role of neutralizing antibodies in hepatitis C virus infection

FULL TEXT (Nov 2011): A rare cause of acute deafness in a patient with HCV

FULL TEXT (Oct 2011): Importance of Minimal Residual Viremia for Relapse Prediction in Patients With Chronic Hepatitis C Genotype 1 Infection

FULL TEXT (Oct 2011): Role of the Endoplasmic Reticulum-associated Degradation (ERAD) Pathway in Degradation of Hepatitis C Virus Envelope Proteins and Production of Virus Particles

FULL TEXT (August 2011): Unusual Draining Nodules in a Patient with Rheumatoid Nodulosis and Hepatitis C Virus Infection

FULL TEXT (July 2011): Inhibition of cyclophilins alters lipid trafficking and blocks hepatitis C virus secret

FULL TEXT (July 2011): NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b

FULL TEXT (July 2011): Improved Reflexive Testing Algorithm for Hepatitis C Infection Using Signal-to-Cutoff Ratios of a Hepatitis C Virus Antibody Assay

FULL TEXT (July 2011): Hepatitis C—Removing Barriers to Diagnosing the “Silent Epidemic”

FULL TEXT (June 2011): Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection

FULL TEXT (June 2011, Accepted Manuscript, ): Identification of interactions in the E1E2 heterodimer of hepatitis C virus important for cell entry

FULL TEXT (April 2011): Association of Serum Cytokine Levels with Treatment Response to Pegylated Interferon and Ribavirin Therapy in Genotype 1 Chronic Hepatitis C Patients

FULL TEXT (March 2011): Patterns and Characteristics of Hepatitis C Transmission Clusters among HIV-Positive and HIV-Negative Individuals in the Australian Trial in Acute Hepatitis C

FULL TEXT (March 2011): Experimental models to study the immunobiology of hepatitis C virus

FULL TEXT (Jan 2011): Neutralizing Antibody-Resistant Hepatitis C Virus Cell-to-Cell Transmission

FULL-TEXT (Jan 2011): A case of hepatitis C virus transmission acquired through sharing a haemodialysis machine

FULL TEXT (Jan 2011): Cervicovaginal shedding of hepatitis C viral RNA is associated with the presence of menstrual or other blood in cervicovaginal fluids

Depression in chronic hepatitis C is associated with low apolipoprotein e levels

March 2011: Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy ("...patients afflicted with HCV who have only mild liver disease...induce neuroinflammation and brain dysfunction.")

June 2011: Influence of hepatitis C virus on neurocognitive function in patients free from other risk factors: validation from therapeutic outcomes

June 2011: Cerebral glucose utilisation in hepatitis C virus infection-associated encephalopathy ("...The hepatitis C virus has a measurable effect on CNS integrity in patients screened for other medical and/or psychiatric comorbidities. Viral clearance has not been demonstrated to abolish these abnormalities.)


SAME SAMPLES  from 2010:

  FULL TEXT (December 2010): Role of simple biomarkers in predicting fibrosis progression in HCV infection

FULL TEXT (Sept. 2010): Hepatitis C Virus Core Protein Induces Neuroimmune Activation and Potentiates Human Immunodeficiency Virus-1 Neurotoxicity

FULL TEXT (July-August 2010): Novel Treatment Strategies for Depression in Patients With Hepatitis C

April 2010: Cognitive efficiency is associated with endogenous cytokine levels in patients with chronic hepatitis C

Further FULL TEXT Samples from 2010


SAME SAMPLES  from 2009:

FULL TEXT (2009): HEPATITIS C VIRUS NEUROINVASION: IDENTIFICATION OF INFECTED CELLS

FULL TEXT (2009): Hepatitis C virus infection and the brain

Further FULL TEXT Samples from 2009


SAME SAMPLES  from 2008:

FULL-TEXT (2008): Cerebral immune activation in chronic hepatitis C infection: A magnetic resonance spectroscopy study

FULL TEXT (2008): High frequency of unrecognized mental disorders in HCV-infected patients

FULL-TEXT (2008): Occult persistence and lymphotropism of hepatitis C virus infection

Further FULL TEXT Samples from 2008


SAME SAMPLES  from 2007:


SAME SAMPLES from 2006:

FULL TEXT (2006): Neurons produce type I interferon during viral encephalitis

FULL TEXT (2006): Occult hepatitis C virus infection: A new form of hepatitis C

FULL TEXT (2006): Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment

FULL TEXT (2006): Altered monoaminergic transporter binding in hepatitis C related cerebral dysfunction: a neuroimmunologial condition?

Further FULL TEXT Samples from 2006


SAME SAMPLES  from 2005:

FULL TEXT (2005): Neurocognitive changes in patients with hepatitis C receiving interferon alfa-2b and ribavirin

FULL TEXT (2005): ACQUIRED HEPATOCEREBRAL DEGENERATION IN HEPATITIS C INFECTION

Further FULL TEXT Samples 2005


SAME SAMPLES from 2004:

FULL TEXT (Oct-Dec 2004): Chronic hepatitis C virus infection and haematological diseases:how established is the link?

FULL TEXT (2004): Identification of Unique Hepatitis C Virus Quasispecies in the Central Nervous System and Comparative Analysis of Internal Translational Efficiency of Brain, Liver, and Serum Variants

Further FULL TEXT Samples  2004


SAMPLE  from 2003:

FULL TEXT (2003): Cerebral dysfunction in chronic hepatitis C infection


SAME SAMPLES  from 2002:

FULL TEXT (2002): Neuropsychological Impairment in Patients With Chronic Hepatitis C

FULL TEXT (2002): Detection of Hepatitis C Virus Sequences in Brain Tissue Obtained in Recurrent Hepatitis C After Liver Transplantation

FULL TEXT (2002): Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid.

FULL TEXT (2002): Hepatitis C and Cognitive Impairment in a Cohort of Patients With Mild Liver Disease


  Wir befolgen die HONcode Prinzipien der Health On the Net Foundation

In compliance with the HONcode   

Non-profit websites for doctor specialist. Without  funding, grants, sponsors, advertisers. ABSOLUTE PRIVACY RESPECT. Visitors data will NOT be recorded. No cookies. No advertisement.

Sito non profit per medici specialisti. Senza finanziamenti, sovvenzioni, sponsor, inserzionisti. L'autrice autofinanzia il suo sito. RISPETTO ASSOLUTO DELLA PRIVACY. I dati dei visitatori non vengono registrati o ceduti a terzi. Non cookies. Non pubblicità.

Non-Profit Web für Fachärzte. Ohne Finanzierung, Zuschüsse, Sponsoren, Inserenten. Die Autorin finanziert ihre Webseite selbst. ABSOLUTER RESPEKT DER PRIVACY. Besucherdaten werden nicht aufgezeichnet oder an Dritte weitergegeben. Keine Cookies. Keine Werbung.


In compliance with the Quality Criteria for Health related Websites (COMMISSION OF THE EUROPEAN COMMUNITIES)


home

© scientific supervision by dr. monika runggaldier up date  03-nov-2011